Journey Medical (DERM) Equity Ratio: 2020-2025
Historic Equity Ratio for Journey Medical (DERM) over the last 4 years, with Sep 2025 value amounting to 0.30.
- Journey Medical's Equity Ratio rose 78.19% to 0.30 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.30, marking a year-over-year increase of 78.19%. This contributed to the annual value of 0.25 for FY2024, which is 5.55% down from last year.
- Latest data reveals that Journey Medical reported Equity Ratio of 0.30 as of Q3 2025, which was up 28.19% from 0.24 recorded in Q2 2025.
- In the past 5 years, Journey Medical's Equity Ratio ranged from a high of 0.43 in Q4 2021 and a low of -0.13 during Q3 2021.
- Over the past 3 years, Journey Medical's median Equity Ratio value was 0.24 (recorded in 2025), while the average stood at 0.20.
- Per our database at Business Quant, Journey Medical's Equity Ratio plummeted by 99.98% in 2023 and then surged by 241,594.88% in 2024.
- Over the past 5 years, Journey Medical's Equity Ratio (Quarterly) stood at 0.43 in 2021, then plummeted by 62.63% to 0.16 in 2022, then surged by 63.98% to 0.26 in 2023, then dropped by 5.55% to 0.25 in 2024, then skyrocketed by 78.19% to 0.30 in 2025.
- Its last three reported values are 0.30 in Q3 2025, 0.24 for Q2 2025, and 0.25 during Q1 2025.